Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Autolus Therapeutics plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 67
- +3 vs. Q1 2022
- Shares held
- 50.8M
- −2.12M (−4.0%) vs. Q1 2022
- Total value
- $143.9M
- −$84.5M (−37.0%) vs. Q1 2022
- New holders
- 14
- 13 more added
- Sold out
- 11
- 18 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 83 | $212.0M |
| Q1 2026 | 84 | $184.4M |
| Q4 2025 | 89 | $277.1M |
| Q3 2025 | 96 | $235.7M |
| Q2 2025 | 94 | $378.6M |
| Q1 2025 | 95 | $261.0M |
| Q4 2024 | 110 | $395.4M |
| Q3 2024 | 101 | $648.5M |
| Q2 2024 | 111 | $620.0M |
| Q1 2024 | 120 | $1.12B |
| Q4 2023 | 99 | $746.6M |
| Q3 2023 | 71 | $258.1M |
| Q2 2023 | 69 | $260.4M |
| Q1 2023 | 65 | $195.1M |
| Q4 2022 | 71 | $204.2M |
| Q3 2022 | 66 | $105.7M |
| Q2 2022 | 67 | $143.9M |
| Q1 2022 | 66 | $228.6M |
| Q4 2021 | 73 | $272.3M |
| Q3 2021 | 59 | $164.2M |
| Q2 2021 | 69 | $169.6M |
| Q1 2021 | 63 | $129.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Autolus Therapeutics plc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Blackstone Group Inc. | 17,985,611 | $50.9M | 0.17% | 00.0% | Unchanged |
| Syncona Portfolio Ltd | 7,346,829 | $20.8M | 29.54% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 5,142,855 | $14.6M | 1.26% | +796,528+18.3% | Added |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $10.6M | 1.00% | 00.0% | Unchanged |
| Polygon Management Ltd. | 3,019,413 | $8.54M | 0.60% | +193,476+6.8% | Added |
| Citadel Advisors LLC | 2,153,657 | $6.09M | 0.01% | −1,358,856−38.7% | Reduced |
| Schroder Investment Management Group | 1,672,732 | $4.73M | 0.01% | 00.0% | Unchanged |
| Pendal Group Limited | 1,365,429 | $3.86M | 0.04% | −9,677−0.7% | Reduced |
| Woodline Partners LP | 726,114 | $2.06M | 0.03% | −69,897−8.8% | Reduced |
| Alphabet Inc. | 698,262 | $1.98M | 0.11% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 626,519 | $1.77M | 0.00% | −173,039−21.6% | Reduced |
| Capital World Investors | 625,000 | $1.77M | 0.00% | −435,579−41.1% | Reduced |
| UBS Oconnor LLC | 584,246 | $1.65M | 0.02% | +584,246 | New |
| LGT Capital Partners Ltd. | 550,000 | $1.56M | 0.05% | +50,000+10.0% | Added |
| DAFNA Capital Management LLC | 496,150 | $1.40M | 0.38% | 00.0% | Unchanged |
| BlackRock Inc. | 467,846 | $1.32M | 0.00% | +81,132+21.0% | Added |
| Cormorant Asset Management, LP | 392,167 | $1.11M | 0.09% | 00.0% | Unchanged |
| FMR LLC | 380,185 | $1.08M | 0.00% | −1,262,100−76.9% | Reduced |
| MAI Capital Management | 365,407 | $1.03M | 0.02% | +365,407 | New |
| Wells Fargo & Company | 363,955 | $1.03M | 0.00% | +124,320+51.9% | Added |
| Ikarian Capital, LLC | 322,217 | $912.0K | 0.38% | −50,000−13.4% | Reduced |
| Millennium Management LLC | 237,659 | $673.0K | 0.00% | +70,093+41.8% | Added |
| Harbor Capital Advisors, Inc. | 164,906 | $467.0K | 0.36% | +1,763+1.1% | Added |
| ExodusPoint Capital Management, LP | 149,035 | $422.0K | 0.01% | +149,035 | New |
| Geode Capital Management, LLC | 133,438 | $377.0K | 0.00% | 00.0% | Unchanged |
| Cetera Investment Advisers | 127,000 | $359.0K | 0.01% | +2,700+2.2% | Added |
| Erste Asset Management GmbH | 120,000 | $339.6K | 0.01% | 00.0% | Unchanged |
| MYDA Advisors LLC | 100,000 | $283.0K | 0.12% | −15,000−13.0% | Reduced |
| Privium Fund Management B.V. | 98,528 | $279.0K | 0.09% | +65,528+198.6% | Added |
| Caxton Associates LP | 89,356 | $253.0K | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 68,383 | $194.0K | 0.00% | −106,876−61.0% | Reduced |
| Legal & General Group Plc | 67,517 | $192.0K | 0.00% | +34,813+106.4% | Added |
| Alps Advisors Inc | 53,931 | $153.0K | 0.00% | −39,502−42.3% | Reduced |
| State Street Corp | 53,927 | $153.0K | 0.00% | −17,973−25.0% | Reduced |
| UBS Group AG | 42,073 | $118.0K | 0.00% | −31,785−43.0% | Reduced |
| Wealth Effects LLC | 38,100 | $108.0K | 0.07% | +6,450+20.4% | Added |
| Acadian Asset Management LLC | 34,888 | $98.0K | 0.00% | +34,888 | New |
| Boothbay Fund Management, LLC | 32,178 | $91.0K | 0.00% | −4,993−13.4% | Reduced |
| Cubist Systematic Strategies, LLC | 21,487 | $61.0K | 0.00% | +21,487 | New |
| Goldman Sachs Group Inc | 21,039 | $60.0K | 0.00% | −354,475−94.4% | Reduced |
| Northeast Financial Consultants Inc | 19,672 | $56.0K | 0.00% | 00.0% | Unchanged |
| Bayshore Asset Management, LLC | 17,500 | $50.0K | 0.04% | +17,500 | New |
| American Portfolios Advisors | 16,925 | $47.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 16,617 | $47.0K | 0.00% | +16,617 | New |
| Jane Street Group, LLC | 14,717 | $42.0K | 0.00% | +14,717 | New |
| Weiss Multi-Strategy Advisers LLC | 13,753 | $39.0K | 0.00% | −723−5.0% | Reduced |
| Blair William & Co | 13,341 | $38.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 12,800 | $36.0K | 0.00% | +12,800 | New |
| Group One Trading, L.P. | 5,900 | $17.0K | 0.00% | +100+1.7% | Added |
| Cannell Capital LLC | 4,001 | $11.0K | 0.00% | +4,001 | New |
| Tower Research Capital LLC (TRC) | 3,454 | $10.0K | 0.00% | +480+16.1% | Added |
| Huntington National Bank | 1,501 | $4.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 957 | $3.00K | 0.00% | −279−22.6% | Reduced |
| Ulland Investment Advisors, LLC | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Total Clarity Wealth Management, Inc. | 1,200 | $3.00K | 0.00% | +1,200 | New |
| BNP Paribas Arbitrage, SA | 1,010 | $2.86K | 0.00% | +1,010 | New |
| Bank of America Corp | 626 | $2.00K | 0.00% | −2,078−76.8% | Reduced |
| Captrust Financial Advisors | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 508 | $1.00K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 177 | $1.00K | 0.00% | −216−55.0% | Reduced |
| Northwestern Mutual Wealth Management Co | 500 | $1.00K | 0.00% | +500 | New |
| Exane Derivatives | 180 | $509 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 44 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 74 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Curi Capital | 137 | $0 | 0.00% | +137 | New |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −382,559−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −371,540−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −27,536−100.0% | Sold out |
| Moloney Securities Asset Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −15,074−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,869−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −3,087−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −982−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −301−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −346−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Golden State Equity Partners | – | – | – | – | Not filed |